Guide to Lipase
Summary
Lipase is a digestive enzyme mainly produced in the pancreas that helps break down dietary fats into smaller components that can be absorbed by the body.
Why It Matters
Lipase levels in blood provide information about pancreatic function and can help detect conditions such as pancreatitis.
Lipase is important for the proper digestion and metabolism of fats. When you eat foods containing fat, the pancreas releases lipase into the small intestine. There, lipase works to break down triglycerides (the main form of dietary fat) into fatty acids and glycerol, which can then be absorbed by the intestinal lining.
Normally, only small amounts of lipase enter the bloodstream. However, when the pancreas is damaged or inflamed, lipase is released directly into the blood. High lipase can be a sign of acute pancreatitis.
Beyond pancreatitis, abnormal lipase levels may also suggest pancreatic cancer, pancreatic cysts, pancreatic trauma, bowel obstruction, or certain kidney diseases that affect the clearance of the enzyme.
Associated Symptoms
Lipase levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health conditions, each with its own symptoms.
Common symptoms that may indicate conditions associated with high lipase (often pancreatitis):
- Upper abdominal pain: Often severe and radiating to the back, can be caused by inflammation of the pancreas
- Nausea and vomiting: Digestive disturbances may be related to pancreatic inflammation and altered digestive enzyme release
- Loss of appetite: Reduced desire to eat may be due to abdominal discomfort and systemic inflammation
- Abdominal tenderness: Sensitivity to touch or pressure in the upper abdomen, potentially reflecting underlying inflammation
- Fever: Elevated body temperature may be associated with the inflammatory response to pancreatic damage
Common symptoms that may indicate conditions associated with low lipase:
- Digestive discomfort after fatty meals: may indicate an inability to properly break down fats leading to gastrointestinal symptoms
- Oily or fatty stools: Undigested fat in stool (steatorrhea), potentially due to insufficient fat digestion
- Unexplained weight loss: Could be a result of malabsorption of nutrients, particularly fats and fat-soluble vitamins
It's important to understand that many factors can cause these symptoms, and lipase levels are just one piece of diagnostic information. The presence of symptoms alongside abnormal lipase provides context for further investigation, but additional testing is typically needed to determine the underlying cause. Very high lipase levels with abdominal pain warrant prompt medical attention, as acute pancreatitis can be a serious and potentially life-threatening condition.
Clinical Ranges
Lab Reference Range: 7-60 U/L
Lifestyle Factors That Can Impact It
Activities that may affect lipase include:
- Alcohol consumption: Regular or excessive alcohol intake can irritate the pancreas and lead to both acute and chronic forms of pancreatitis, resulting in elevated lipase levels.
- High-fat diet: Consuming large amounts of fatty foods can temporarily increase lipase as the body works to digest the fat.
- Smoking: Tobacco use is associated with an increased risk of pancreatic damage and inflammation, potentially affecting lipase levels.
- Hydration: Maintaining proper hydration helps support overall pancreatic function.
Other Factors That Can Impact It
Genetic Conditions
- Cystic fibrosis: Caused by mutations in the CFTR gene, affects the release of pancreatic secretions and can impact lipase levels.
Medical Conditions
- Pancreatitis: Inflammation of the pancreas damages pancreatic cells, leaking lipase directly into the bloodstream rather than the digestive tract.
- Pancreatic cancer: Malignant cells can obstruct pancreatic ducts and cause tissue damage, leading to elevated lipase levels. Conversely, pancreatic cancer can also inhibit enzyme production, resulting in low lipase levels and malabsorption
- Kidney disease: The kidneys help clear lipase from the blood, so impaired kidney function can result in higher levels of the enzyme.
- Peptic ulcer disease: Inflammation near the pancreas can sometimes affect pancreatic function and lipase release.
- Bowel obstruction or infarction: These conditions can cause secondary pancreatic inflammation, resulting in elevated lipase.
Medications and Supplements
- Certain opioids
- Statins
- Some antibiotics (tetracyclines, macrolides)
- Thiazide diuretics
- ACE inhibitors
- Birth control pills
- Cholinergic drugs
- Glucocorticoids
- Non-steroidal anti-inflammatory drugs (NSAIDs)
Individual Factors
- Age: Older adults have different reference ranges.
- Pregnancy: Normal physiological changes during pregnancy can sometimes affect lipase levels.
- Body mass index: Obesity is associated with increased risk of gallstones and metabolic dysfunction-associated steatotic liver disease (MASLD), both of which can impact pancreatic function and lipase levels.
Testing Accuracy and Stability
Factors That Can Affect the Accuracy of Your Test
- Having a recent meal, especially high-fat (you may need to fast 8-12 hours before the test)
- Kidney function (decreased clearance can elevate levels)
- Certain medications taken within 24 hours of testing
How It Relates to Other Markers
Other tests can provide insights about health status when they're viewed alongside lipase results. These tests may include:
- Amylase: This is a pancreatic enzyme that may rise alongside lipase in acute pancreatitis. Amylase testing helps confirm pancreatic involvement and can help track the timeline of pancreatic injury.
- Complete blood count (CBC): Elevated white blood cells can indicate inflammation or infection.
- Liver function tests: Abnormalities may suggest gallstone pancreatitis or other conditions affecting both the liver and pancreas.
- Abdominal imaging (ultrasound, CT, or MRI): These tests visualize the pancreas and surrounding structures to identify inflammation, stones, tumors, or structural abnormalities.
- Triglycerides: Very high triglyceride levels (>1000 mg/dL) can cause acute pancreatitis.
What Results May Mean in the Context of Other Markers
- High Lipase + High Amylase: May suggest acute pancreatitis.
- High Lipase + High Liver Enzymes (ALT, AST, ALP): May suggest papillary stenosis or gallstone pancreatitis, typically caused by gallstones obstructing the common bile duct.
- High Lipase + Very High Triglycerides: May suggest hypertriglyceridemia-induced pancreatitis.
- High Lipase + High Inflammatory Markers (CRP, ESR): May suggest more severe pancreatic inflammation.
Follow-up Considerations
If lipase is high, your provider may make some of the following recommendations. You should always speak to your doctor if you have medical questions or before making medical decisions.
When Re-Testing May Be Appropriate
- If no symptoms are present and you are on a medication that can impact lipase levels, follow the instructions of your provider to consider re-testing your lipase after you've held your medication (if appropriate)
Additional Testing Your Doctor May Consider
- Fecal elastase test to assess exocrine pancreatic function
- Endoscopic ultrasound for detailed imaging of pancreatic ducts and tissue
- MRCP (Magnetic Resonance Cholangiopancreatography) to visualize the biliary and pancreatic ducts
- Genetic testing if hereditary pancreatitis is suspected
- Glucose tolerance test to assess for pancreatic endocrine insufficiency
When Additional Care May Be Warranted
- Severe abdominal pain, especially if radiating to the back
- Persistent vomiting
- Fever above 101°F with abdominal symptoms
- Jaundice (yellowing of skin or eyes)
- Lipase levels more than three times the upper limit of normal
- Signs of shock (rapid heartbeat, low blood pressure, confusion)
- Worsening symptoms despite initial treatment
Bibliography
References
1. Lippi, Giuseppe, Martina Valentino, and Gianfranco Cervellin. "Laboratory Diagnosis of Acute Pancreatitis: In Search of the Holy Grail." Critical Reviews in Clinical Laboratory Sciences, vol. 49, no. 1, 2012, pp. 18--31. https://doi.org/10.3109/10408363.2012.658354.
2. Ismail, Ola Z., and Vivek Bhayana. "Lipase or Amylase for the Diagnosis of Acute Pancreatitis?" Clinical Biochemistry, vol. 50, no. 18, 2017, pp. 1275--1280. https://doi.org/10.1016/j.clinbiochem.2017.07.003.
3. Hameed, Ammar M., Vincent W.T. Lam, and Henry C. Pleass. "Significant Elevations of Serum Lipase Not Caused by Pancreatitis: A Systematic Review." HPB, vol. 17, no. 2, 2015, pp. 99--112. https://doi.org/10.1111/hpb.12277.
4. Banks, Peter A., et al. "Classification of Acute Pancreatitis---2012: Revision of the Atlanta Classification and Definitions by International Consensus." Gut, vol. 62, no. 1, 2013, pp. 102--111. https://doi.org/10.1136/gutjnl-2012-302779.
5. Lankisch, Paul Georg, Minoti Apte, and Peter A. Banks. "Acute Pancreatitis." The Lancet, vol. 386, no. 9988, 2015, pp. 85--96. https://doi.org/10.1016/S0140-6736(14)60649-8.
6. Tenner, Scott, et al. "American College of Gastroenterology Guideline: Management of Acute Pancreatitis." The American Journal of Gastroenterology, vol. 108, no. 9, 2013, pp. 1400--1415. https://doi.org/10.1038/ajg.2013.218.
7. Greenberg, Jeffrey A., et al. "Clinical Practice Guideline: Management of Acute Pancreatitis." Canadian Journal of Surgery, vol. 59, no. 2, 2016, pp. 128--140. https://doi.org/10.1503/cjs.015015.
8. Vege, Santhi S., et al. "Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association Institute Technical Review." Gastroenterology, vol. 154, no. 4, 2018, pp. 1103--1139. https://doi.org/10.1053/j.gastro.2018.01.031.
9. Yadav, Dhiraj, and Albert B. Lowenfels. "The Epidemiology of Pancreatitis and Pancreatic Cancer." Gastroenterology, vol. 144, no. 6, 2013, pp. 1252--1261. https://doi.org/10.1053/j.gastro.2013.01.068.
10. Forsmark, Chris E., Santhi S. Vege, and C. Mel Wilcox. "Acute Pancreatitis." New England Journal of Medicine, vol. 375, no. 20, 2016, pp. 1972--1981. https://doi.org/10.1056/NEJMra1505202.
11. Pirahanchi Y, Sharma S. Biochemistry, Lipase. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537346/
12. Boot C. A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions. Ann Clin Biochem. 2014 Mar;51(Pt 2):151-66. doi: 10.1177/0004563213503819.
13. Kamil Faiz FZ, Mehrabian S, Saad M, Aisenberg GM. Prognostic value of serum lipase levels in patients with small bowel obstruction. Proc (Bayl Univ Med Cent). 2018 Apr 10;31(3):276-279. doi: 10.1080/08998280.2018.1446637.
14. Sliwińska-Mossoń M, Milnerowicz H. Wpływ palenia tytoniu na aktywność lipazy u pacjentów z procesem zapalnym trzustki [Influence of tobacco smoking on lipase activity in patients with pancreatitis]. Przegl Lek. 2005;62(10):1058-61.
15. Kamil Faiz FZ, Mehrabian S, Saad M, Aisenberg GM. Prognostic value of serum lipase levels in patients with small bowel obstruction. Proc (Bayl Univ Med Cent). 2018 Apr 10;31(3):276-279. doi: 10.1080/08998280.2018.1446637.
16. Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991 Oct;32(11):2970-5.
17. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010 Jul;23(3):590-615. doi: 10.1128/CMR.00078-09.
18. Chaaban N, Kshatriya S. Thiazide-Induced Pancreatitis. Kans J Med. 2022 Jun 20;15(2):220-221. doi: 10.17161/kjm.vol15.16534.
19. Hussain MS, Deliwala SS, Ponnapalli A, Modi V, Kanugula A, Elbedawi MM, Bachuwa G. Angiotensin-Converting Enzyme (ACE) Inhibitors and Pancreatitis: A Potential Dose-dependent Relationship. Eur J Case Rep Intern Med. 2020 Oct 28;7(12):001956. doi: 10.12890/2020_001956.
20. Bhatt S, Perez A, Sarmiento E, Alfonso T, Shah S, Hernandez Borges S. Hypertriglyceridemia-Induced Acute Pancreatitis Exacerbated by Combined Oral Contraceptive Use: A Case Report. Cureus. 2024 Jul 14;16(7):e64537. doi: 10.7759/cureus.64537.
21. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism. 2011 Nov;60(11):1500-10. doi: 10.1016/j.metabol.2011.06.012.
22. Karsenti D, Bacq Y, Bréchot JF, Mariotte N, Vol S, Tichet J. Serum amylase and lipase activities in normal pregnancy: a prospective case-control study. Am J Gastroenterol. 2001 Mar;96(3):697-9. doi: 10.1111/j.1572-0241.2001.03607.x.
23. Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):623-35. doi: 10.1016/j.bpg.2014.07.013.
24. Kern PA. Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity. J Nutr. 1997 Sep;127(9):1917S-1922S. doi: 10.1093/jn/127.9.1917S.
25. Basnayake C, Ratnam D. Blood tests for acute pancreatitis. Aust Prescr. 2015 Aug;38(4):128-30. doi: 10.18773/austprescr.2015.043.
26. Gulhar R, Ashraf MA, Jialal I. Physiology, Acute Phase Reactants. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519570/
27. Sollie S, Michaud DS, Sarker D, Karagiannis SN, Josephs DH, Hammar N, Santaolalla A, Walldius G, Garmo H, Holmberg L, Jungner I, Van Hemelrijck M. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study. BMC Cancer. 2019 Aug 29;19(1):858. doi: 10.1186/s12885-019-6082-6.




